Delivery Order 36C26120D0064-36C26121N0382
Award Date 4/1/21
Potential Completion Date 3/31/22
Potential Value $32K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Francisco, CA 94108, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $49,084.18 firm fixed price delivery order contract to Veracyte Labs SD Corp, a division of Decipher Biosciences, Inc., for prostate cancer testing services. To be performed in San Francisco, California, the contract calls for Decipher Biosciences to provide its Decipher Prostate Cancer Testing to aid in clinical decision making and active surveillance for prostate cancer...
- This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 21 (VISN 21) of the U.S. Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc. The contract is for the provision of Veracyte's proprietary Decipher Prostate Cancer Testing, Packaging, and Transport services to the VA San Francisco healthcare facility. The contract has a ceiling value of $648,118.00 and a period of performance through...
- This is a firm fixed-price delivery order awarded to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 10. The $84,255.34 contract is for the company's Decipher Prostate Cancer Testing services, which provide genomic analysis to help clinicians make more informed treatment decisions for prostate cancer patients. Veracyte is a for-profit organization that specializes in advanced molecular...
- Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., was awarded a $324,059 delivery order by Veterans Integrated Service Network 2 on October 23, 2025, for the provision of Decipher Prostate Cancer testing services at the Northport Veterans Affairs Medical Center. The contract, which is not set aside for any specific business category, is structured as a firm fixed-price delivery order under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule...
- This is a firm fixed price contract awarded by the Veterans Health Administration's Veterans Integrated Service Network 8 (VISN 8) to Veracyte Labs SD Corporation, a division of Veracyte, Inc. The contract, valued at $372,667.85, is for the delivery of the Decipher Prostate Cancer Test, a specialized genomic diagnostic service that analyzes tumor gene expression patterns to help clinicians assess prostate cancer risk and guide treatment decisions. The contract is a Blanket Purchase Agreement...
- This task order extends the period of performance for six months on an indefinite-delivery, indefinite-quantity contract held by Veracyte Labs SD Corp, a division of Decipher Biosciences, Inc. The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 issued this firm fixed price delivery order, worth $32,405.90, to continue providing the proprietary Decipher Prostate Cancer Test. No set-aside designation was used for this award made under the larger...
- This firm fixed price delivery order was awarded by the Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, operating through its Decipher Biosciences, Inc. division. The $9,722 contract calls for the provision of Veracyte's proprietary Decipher Molecular Prostate Oncology Assay, which utilizes genomic testing to analyze tumor gene expression patterns and aid in personalized treatment planning for prostate cancer patients. The award was made under Veracyte's existing Federal...
- This delivery order, awarded to Veracyte Labs SD Corporation (a division of Decipher Biosciences, Inc.) on April 15, 2023, represents Option Year 2 of a contract to provide Decipher Prostate Testing services to Veterans Integrated Service Network 10 (VISN 10). The contract, valued at $408,314.34 on a firm fixed-price basis, will be performed in Ann Arbor, Michigan, with an ultimate completion date of November 14, 2025. This award was not subject to any small business set-aside and is established...
- Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., received a $648,118 delivery order from Veterans Integrated Service Network 10 (VISN 10) for the Decipher Prostate Testing service at locations in Ann Arbor, Saginaw, and Battle Creek, Michigan, with completion expected by November 14, 2030. This non-set-aside contract, awarded on November 15, 2025, is issued under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) and represents work...
- The Department of Veterans Affairs, Veterans Integrated Service Network 8 (VISN 8), awarded a delivery order valued at $96,960 to Veracyte, Inc. for gene testing services. The award, issued on February 5, 2026, is a firm fixed-price delivery order with an ultimate completion date of February 4, 2027, and carries no small business set-aside designation. The contract will be performed in South San Francisco, California, where Veracyte maintains its headquarters. This delivery order is issued under...
- 36C26120D0064Indefinite Delivery Contract
- 36C26120D0064-36C26121N0382Delivery Order
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $32,405.90 firm fixed price delivery order to Veracyte Labs SD Corp, a division of Decipher Biosciences, Inc., for the task of providing prostate cancer testing services. Performance will take place in San Francisco, California by March 31, 2022. The contract has no set-aside designation. As the award supports prostate cancer testing, it is likely associated with the VA's efforts to provide healthcare services to veterans, including cancer screening, diagnosis and treatment through its integrated network of medical centers and clinics.
Generated 1/2/24, 7:42 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($23k) | 7/12/22 | |
| Not listed | Not listed | $55.1k | 3/12/21 |